NCT05985161: A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- State
- Under way
- Phase
- Phase 2
- People
- 45 planned
- Started
- 1 Aug 2023
- Primary completion
- 1 Aug 2029
- Arms
- Cohort A.1 Wilms Tumor, Cohort B.1 Rhabdoid Tumor, Cohort C.1 MPNST, Cohort D.1 Other Solid Tumor, Cohort E.1g BCOR driven sarcoma
- Results
- None posted
- 1 Aug 2023: Trial started
- 14 Aug 2023: Trial registered